Citeline’s annual analysis of completed clinical trials for 2023 reveals a clear break from the COVID-19 pandemic-driven fluctuations seen since 2020. The industry has finally got back where it was at the end of the last decade now that the focus on infectious diseases and vaccines has tapered off and disruptions to other trials have come to an end.
Key Takeaways
-
Nearly 11% more clinical trials completed in 2023 than in 2022.
Citeline’s TrialTrove database recorded 4,295 industry-sponsored trials from Phase I to Phase III/IV that either reached completed status or reported...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?